Citation Impact
Citing Papers
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein
2007 StandoutNobel
Ionotropic and metabotropic glutamate receptor structure and pharmacology
2005
Antidepressant effects of ketamine in depressed patients
2000 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Glutamate receptor ion channels
2005 Standout
5-Hydroxytryptamine pathways in anxiety and its treatment
1995
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Altered glutamatergic transmission in neurological disorders: From high extracellular glutamate to excessive synaptic efficacy
1997
Kynurenines in the mammalian brain: when physiology meets pathology
2012
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse
2007
Memantine in Moderate-to-Severe Alzheimer's Disease
2003 Standout
Characterization of the binding of two novel glycine site antagonists to cloned NMDA receptors: evidence for two pharmacological classes of antagonists
2000
Channel opening and gating mechanism in AMPA-subtype glutamate receptors
2017 StandoutNatureNobel
Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs
2003
Glutamate uptake
2001 Standout
Is the forced swimming test a suitable model for revealing antidepressant activity?
1988
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Structural determinants of the blocker binding site in glutamate and NMDA receptor channels
1998
Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia
1989
Subunit- and site-specific pharmacology of the NMDA receptor channel
1999
Mice Deficient in Golf Are Anosmic
1998 StandoutNobel
Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer’s Disease
2004
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Amantadine Inhibits NMDA Receptors by Accelerating Channel Closure during Channel Block
2005
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Memantine binding to a superficial site on NMDA receptors contributes to partial trapping
2009
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
The age of anxiety: role of animal models of anxiolytic action in drug discovery
2011
Neuroprotective and symptomatological action of memantine relevant for alzheimer’s disease — a unified glutamatergic hypothesis on the mechanism of action
2000
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
1999
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 StandoutNobel
The Mechanism of Action of Novel Antipsychotic Drugs
1991
Potential Antidepressive Properties of Amantadine, Memantine and Bifemelane
1993
Interaction of memantine and amantadine with agonist‐unbound NMDA‐receptor channels in acutely isolated rat hippocampal neurons
1998
Two Blocking Sites of Amino-Adamantane Derivatives in Open N-Methyl-d-Aspartate Channels
1998
Dynorphin displaces binding at the glycine site of the NMDA receptor in the rat striatum
2006
The NR2B-specific Interactions of Polyamines and Protons with theN-Methyl-d-aspartate Receptor
1997
Mice Deficient in Lysosomal Acid Phosphatase Develop Lysosomal Storage in the Kidney and Central Nervous System
1997
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Kynurenic acid leads, dopamine follows: A new case of volume transmission in the brain?
2006
Cocaine and Other Stimulants
1988 Standout
Alzheimer's Disease
2004 Standout
d-amphetamine and l-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the α2C-adrenergic receptor subtype
1998 StandoutNobel
Structural Bases of Desensitization in AMPA Receptor-Auxiliary Subunit Complexes
2017 StandoutNobel
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Dopamine D-1 and D-2 receptors in relation to reward and performance: A case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs
1990
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia
2004
Neurocircuitry of Addiction
2009 Standout
Activity-dependent regulation of dendritic synthesis and trafficking of AMPA receptors
2004 StandoutNobel
Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review
2006
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Specific Functional Effects of Memantine Treatment in Patients with Moderate to Severe Alzheimer’s Disease
2004
Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes
1997
Pharmacological Implications of Two Distinct Mechanisms of Interaction of Memantine with N-Methyl-d-aspartate-Gated Channels
2005
An EEG investigation on nabilone, a synthetic cannabinoid, in rabbits
1986
Catecholamine receptor agonists
1976
Elucidation of AMPA receptor–stargazin complexes by cryo–electron microscopy
2016 StandoutScienceNobel
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Clonidine-induced locomotor hyperactivity in rats
1977
Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors
1976
Structural Modifications to anN-Methyl-d-aspartate Receptor Antagonist Result in Large Differences in Trapping Block
2001
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis
1985 StandoutNobel
EEG and behavioral effects of natural, synthetic and biosynthetic cannabinoids
1973
Predictive Reward Signal of Dopamine Neurons
1998 Standout
Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp5) revealed by doubly deficient mice
2001 StandoutNobel
Pharmacological characterization of serotonin receptors in the facial motor nucleus: A microiontophoretic study
1980
Ethenesulfonyl Fluoride (ESF): An On-Water Procedure for the Kilogram-Scale Preparation
2016 StandoutNobel
Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: Evidence for two different mechanisms of action
1978
Reversible Photocontrol of Biological Systems by the Incorporation of Molecular Photoswitches
2013 StandoutNobel
The Glutamate Receptor Ion Channels
1999 Standout
The time course of neuroleptic therapy for psychosis: role of learning processes and implications for concepts of psychotic illness
1987
Structural modifications to an N-methyl-D-aspartate receptor antagonist result in large differences in trapping block.
2001
Evidence for catecholamine involvement in the suppression of locomotor activity due to hypoxia
1973
Pathophysiology of Sleep Apnea
2010 Standout
Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist clonidine
1975
Does dopamine play a role in schizophrenia?
1977 StandoutNobel
A neuropharmacological investigation of some trans-tetrahydrocannabinol derivatives
1969
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
1999 Standout
3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors
1981 StandoutNobel
The glutamate receptor ion channels.
1999
Shuttle-box deficits induced by inescapable shocks in rats: Reversal by the beta-adrenoreceptor stimulants clenbuterol and salbutamol
1986
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
Effects on the 5-hydroxytryptamine-induced head-twitch of drugs with selective actions on alpha1 and alpha2-adrenoceptors
1982
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
1983 Standout
Evaluation and Biological Properties of Reactive Ligands for the Mapping of the Glycine Site on theN-Methyl-d -aspartate (NMDA) Receptor
1999
Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region
1996 StandoutScience
Differences in Degree of Trapping of Low-Affinity Uncompetitive N-Methyl-d-aspartic Acid Receptor Antagonists with Similar Kinetics of Block
1999
The role of dopamine in the discriminative stimulus properties of cocaine
1980
Receptor Sensitivity and the Mechanism of Action of Antidepressant Treatment
1981
Dopamine Receptors: From Structure to Function
1998 Standout
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
1987 StandoutScience
Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively
1982
Functional and biochemical aspects of catecholamine metabolism in brain under hypoxia
1975 StandoutNobel
Works of L Baran being referenced
The influence of neuroleptics on the behavioural effect of 5-hydroxytryptophan.
1978
Novel Systemically Active Antagonists of the Glycine Site of the N-Methyl-d-aspartate Receptor: Electrophysiological, Biochemical and Behavioral Characterization
1997
Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo
1995
Activation of serotonin (5-HT)1A receptors inhibits amphetamine sensitization in mice
2000
The effects of clozapine, thioridazine and phenoxybenzamine on the action of drugs stimulating the central catecholamine receptors.
1974
The central action of clozapine.
1974
Electroencephalographic and behavioral analysis of drug effects on an instrumental reward discrimination in rabbits
1963
The role of nitric oxide in chemically- and electrically-induced seizures in mice
1996
The effect of chronic treatment with antidepressant drugs on salbutamol-induced hypoactivity in rats
1983
The central action of pizotifen
1979
Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
1997
[Effects of certain hallucinogens on the electroencephalogram and conditioned behavior of the rabbit].
1966
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative
1974
The central antiserotonergic action of mianserin
1978
The anxiolytic-like effects of 5-hydroxytryptamine3 (5-HT3) receptor antagonists.
1993
The effect of clonidine on locomotor activity in mice
1972
The central antiserotonin activity of neuroleptics.
1978
Effect of clonidine on the 5-hydroxytryptamine and 5-hydroxyindoleacetic acid brain levels
1973